Cargando…

Polymeric immunoglobulin receptor deficiency exacerbates autoimmune hepatitis by inducing intestinal dysbiosis and barrier dysfunction

Autoimmune hepatitis (AIH) is an immune-mediated inflammatory liver disease with unclear pathogenesis. The gut microbiota and intestinal barrier play an essential role in AIH. Polymeric immunoglobulin receptor (pIgR) is a central component of mucosal immunity. Herein, we aimed to test the hypothesis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Hongwei, Lin, Jing, Pan, Tongtong, Li, Ting, Jiang, Huimian, Fang, Yan, Wang, Yuxin, Wu, Faling, Huang, Jia, Zhang, Huadong, Chen, Dazhi, Chen, Yongping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884241/ https://www.ncbi.nlm.nih.gov/pubmed/36709322 http://dx.doi.org/10.1038/s41419-023-05589-3

Ejemplares similares

Correction: Polymeric immunoglobulin receptor deficiency exacerbates autoimmune hepatitis by inducing intestinal dysbiosis and barrier dysfunction
por: Lin, Hongwei, et al.
Publicado: (2023)

GPX4-Regulated Ferroptosis Mediates S100-Induced Experimental Autoimmune Hepatitis Associated with the Nrf2/HO-1 Signaling Pathway
por: Zhu, Lujian, et al.
Publicado: (2021)

Cryptococcal Meningitis in HIV-Negative Patients: A 12-Year Single-Center Experience in China
por: Huang, Yu, et al.
Publicado: (2023)

Intestinal Dysbiosis and Autoimmune Pancreatitis
por: Yoshikawa, Tomoe, et al.
Publicado: (2021)

Intestinal Dysbiosis and Tryptophan Metabolism in Autoimmunity
por: Brown, Josephine, et al.
Publicado: (2020)

Dysbiosis and Intestinal Barrier Dysfunction in Pediatric Congenital Heart Disease Is Exacerbated Following Cardiopulmonary Bypass
por: Salomon, Jeffrey, et al.
Publicado: (2021)

Cephalosporins-induced intestinal dysbiosis exacerbated pulmonary endothelial barrier disruption in streptococcus pneumoniae-infected mice
por: Wang, Jia-Feng, et al.
Publicado: (2022)

Constipation induced gut microbiota dysbiosis exacerbates experimental autoimmune encephalomyelitis in C57BL/6 mice
por: Lin, Xiuli, et al.
Publicado: (2021)

Partners in Leaky Gut Syndrome: Intestinal Dysbiosis and Autoimmunity
por: Kinashi, Yusuke, et al.
Publicado: (2021)

Restraint Stress in Hypertensive Rats Activates the Intestinal Macrophages and Reduces Intestinal Barrier Accompanied by Intestinal Flora Dysbiosis
por: Wang, Tiantian, et al.
Publicado: (2021)

Dietary Copper Plays an Important Role in Maintaining Intestinal Barrier Integrity During Alcohol-Induced Liver Disease Through Regulation of the Intestinal HIF-1α Signaling Pathway and Oxidative Stress
por: Lin, Hongwei, et al.
Publicado: (2020)

Fungal Dysbiosis and Intestinal Inflammation in Children With Beta-Cell Autoimmunity
por: Honkanen, Jarno, et al.
Publicado: (2020)

Intestinal Dysbiosis in, and Enteral Bacterial Therapies for, Systemic Autoimmune Diseases
por: Marietta, Eric, et al.
Publicado: (2020)

Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases
por: Stolfi, Carmine, et al.
Publicado: (2022)

Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children
por: De Palma, Giada, et al.
Publicado: (2010)

High-fat diet-induced intestinal dysbiosis is associated with the exacerbation of Sjogren’s syndrome
por: Zhang, Minjie, et al.
Publicado: (2022)

microRNA‐143‐3p attenuated development of hepatic fibrosis in autoimmune hepatitis through regulation of TAK1 phosphorylation
por: Tu, Hanxiao, et al.
Publicado: (2019)

Taraxasterol ameliorates dextran sodium sulfate-induced murine colitis via improving intestinal barrier and modulating gut microbiota dysbiosis: Taraxasterol ameliorates colitis via intestinal barrier and gut microbiota dysbiosis
por: Li, Chen, et al.
Publicado: (2022)

Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis
por: Iacob, Simona, et al.
Publicado: (2019)

Intestinal TLR4 deletion exacerbates acute pancreatitis through gut microbiota dysbiosis and Paneth cells deficiency
por: Qi-Xiang, Mei, et al.
Publicado: (2022)

Hydrogen Sulfide Protects Against Ammonia-Induced Neurotoxicity Through Activation of Nrf2/ARE Signaling in Astrocytic Model of Hepatic Encephalopathy
por: Jin, Xiaozhi, et al.
Publicado: (2020)

Intestinal dysbiosis exacerbates the pathogenesis of psoriasis-like phenotype through changes in fatty acid metabolism
por: Zhao, Qixiang, et al.
Publicado: (2023)

Oxidation of fish oil exacerbates alcoholic liver disease by enhancing intestinal dysbiosis in mice
por: Feng, Ruibing, et al.
Publicado: (2020)

Dysbiosis, gut–blood barrier rupture and autoimmune response in rheumatoid arthritis and schizophrenia
por: Maślińska, Maria, et al.
Publicado: (2021)

Neonatal intestinal dysbiosis
por: Underwood, Mark A., et al.
Publicado: (2020)

Carbon dots induce pathological damage to the intestine via causing intestinal flora dysbiosis and intestinal inflammation
por: Jia, Mengmeng, et al.
Publicado: (2023)

Dysbiosis of the intestinal microbiota in neurocritically ill patients and the risk for death
por: Xu, Ruoting, et al.
Publicado: (2019)

Menstrual blood‐derived mesenchymal stem cells attenuate inflammation and improve the mortality of acute liver failure combining with A2AR agonist in mice
por: Chen, Dazhi, et al.
Publicado: (2021)

Probiotics treatment ameliorated mycophenolic acid-induced colitis by enhancing intestinal barrier function and improving intestinal microbiota dysbiosis in mice
por: Zhang, Pengpeng, et al.
Publicado: (2023)

Tributyrin alleviates gut microbiota dysbiosis to repair intestinal damage in antibiotic-treated mice
por: Yang, Ning, et al.
Publicado: (2023)

Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer
por: Ahmad Kendong, Siti Maryam, et al.
Publicado: (2021)

Piglet cardiopulmonary bypass induces intestinal dysbiosis and barrier dysfunction associated with systemic inflammation
por: Salomon, Jeffrey D., et al.
Publicado: (2023)

Intestinal Dysbiosis, the Tryptophan Pathway and Nonalcoholic Steatohepatitis
por: Chen, Jiezhong, et al.
Publicado: (2022)

Fecal microbiota transplantation and bacterial consortium transplantation have comparable effects on the re-establishment of mucosal barrier function in mice with intestinal dysbiosis
por: Li, Ming, et al.
Publicado: (2015)

Transglutaminases in Dysbiosis As Potential Environmental Drivers of Autoimmunity
por: Lerner, Aaron, et al.
Publicado: (2017)

Gut dysbiosis in autoimmune diseases: Association with mortality
por: Chang, Sung-Ho, et al.
Publicado: (2023)

A High-Fat, High-Cholesterol Diet Promotes Intestinal Inflammation by Exacerbating Gut Microbiome Dysbiosis and Bile Acid Disorders in Cholecystectomy
por: Xu, Fusheng, et al.
Publicado: (2023)

Clostridium butyricum Modulates the Microbiome to Protect Intestinal Barrier Function in Mice with Antibiotic-Induced Dysbiosis
por: Hagihara, Mao, et al.
Publicado: (2019)

Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients
por: Pan, Zhaoyi, et al.
Publicado: (2023)

Intestinal barrier dysfunction in murine sickle cell disease is associated with small intestine neutrophilic inflammation, oxidative stress, and dysbiosis
por: Lewis, Caitlin V., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_710b8fj2ci7ra2afjt5v331kfe